The mechanism of the recognition of methionine by Escherichia coli methionyl-tRNA synthetase was examined by a kinetic study of the recognition of methionine analogues in the ATP-PPi exchange reaction and the tRNA-aminoacylation reaction. The results show that the recognition mechanism consists of three parts: (1) the recognition of the size, shape and chemical nature of the amino acid side chain at the methionine-binding stage of the reaction; (2) the recognition of the length of the side chain at the stage of aminoacyladenylate complex-formation; (3) the recognition of the sulphur atom in the side chain at the stage of methionyl-tRNA formation. It is proposed that the sulphur atom interacts withthe enzymeto induce aconformational change. Amodel ofthe active site incorporating the mechanism of methionine recognition is presented.
Although aminoacyl-tRNA synthetases each recognize specifically only one naturally occurring amino acid, many have been found to recognize a wide variety of amino acid analogues (Loftfield, 1972) . A study of the recognition of a range of amino acid analogues in the reactions of aminoacyl-tRNA synthesis can indicate some of the properties of the amino acid side chain that are important in the specific interaction between an amino acid and its specific aminoacyl-tRNA synthetase (Old & Jones, 1976) and thus lead to an understanding of the recognition mechanism.
The reaction catalysed by most of the aminoacyltRNA synthetases occurs in three stages. The first stage is the binding of the amino acid and ATP to the enzyme (Allende et al., 1970) , and this is followed by the formation of an enzyme-bound aminoacyladenylate complex (Allende & Allende, 1971) , accompanied by the release of PPI. The recognition of an amino acid analogue in these two stages can be investigated by using the ATP-PP, exchange reaction.
The recognition of an analogue at the binding stage is measured by its Km value in the reaction, and the Vmax. is a measure of the ability of the analogue to form an aminoacyl-adenylate complex. Some analogues such as amino acid esters and D-amino acids have been found to bind to the synthetase, but are unable to form an aminoacyl-adenylate complex (Bruton & Hartley, 1968; Owens & Bell, 1970) . Such analogues will competitively inhibit the ATP-PP1 exchange reaction. The third stage of the aminoacylation reaction is the binding of tRNA to the enzymebound aminoacyl-adenylate complex and the subsequent transfer of the amino acid to the tRNA molecule. Ebel et al. (1973) have proposed that the recognition of tRNA at this stage is a two-step mechanism. The first step is the binding of the tRNA molecule and possibly depends on the recognition of the overall shape of the tRNA molecule by the enzyme. The second step involves the ability of the tRNA molecule to be aminoacylated and may depend on some specific property of the nucleotide sequence that is recognized at the active site of the enzyme. The recognition of an amino acid analogue in the third step of the aminoacylation reaction could not be measured directly by using the aminoacylation reaction, since radiolabelled analogues were not available. However, it was measured indirectly by determining the ability of the analogue to inhibit the extent of aminoacyl-tRNA formation in the overall reaction (Old & Jones, 1976) .
To study the recognition of methionine in the first two stages of the aminoacylation reaction we have compared the kinetic parameters exhibited by methionine with those of ethionine, homocysteine, norleucine, norvaline, a-aminobutyric acid, Smethylcysteine and S-ethylcysteine in the ATP-PPI exchange reaction by using pure methionyl-tRNA synthetase from Escherichia coli. These results have been compared with the inhibitory effects of these analogues on the extent of methionyl-tRNA formation. From the results of these studies we have determined some of the features of the methionine side chain which are involved in the recognition mechanism and have incorporated these findings into a suggested model for the recognition of methionine at the active site of E. coli methionyl-tRNA synthetase and formation of the methionine-tRNA bond.
Materials and Methods Chemicals
Reagent-grade chemicals were used. S-Ethyl-Lcysteine was a gift from Dr (1967) , which yielded highly purified tRNAMCe, and (2) chromatography of purified tRNAMCt obtained in step (1) on arginineagarose (Jay & Jones, 1974) , which separated the two tRNAMCt species, tRNA et and tRNAICt. E. coli methionyl-tRNA synthetase was a gift from Dr. C. Bruton, Department of Biochemistry, Imperial College, University of London.
ATP-PP, exchange assay
The ATP-PP1 exchange assay was carried out by the procedure described by Calendar & Berg (1966 albumin and either L-methionine or an amino acid analogue as indicated, in a total volume of 1 ml. The reaction was initiated by adding 1.9,g of pure methionyl-tRNA synthetase and the reaction mixture incubated at 37°C. The reaction was stopped after an appropriate time by the addition of 0.5 ml of 7% (v/v) HC104, and 0.2ml of an acid-washed charcoal suspension (15 % dry weight in water) was added to the reaction mixture. After mixing thoroughly, the mixture was filtered through a Whatman GF/C glass-fibre disc. The disc was washed with 3 x lOml of water, dried on an aluminium planchet at 60°C for 15min and assayed for radioactivity in a gas-flow counter (Nuclear-Chicago) equipped with a Micromil end window. Assay of amino acid-acceptor activity of tRNA
The aminoacylation of tRNA and the effect of analogues on the extent of aminoacylation were assayed as described previously (Old & Jones, 1976) , except that the synthetase preparation from E. coli was replaced by 1.5,ug of pure methionyl-tRNA synthetase and the crude tRNA was replaced by 0.05 A260 unit of either purified tRNAmet or tRNAICt.
Results
Each analogue of methionine was first tested for its ability to support the ATP-PP1 exchange reaction. The results of these experiments are presented in Table 1 . The amount of ATP-PP, exchange stimulated by each analogue has been converted for comparison purposes into a percentage ofthe amount stimulated by methionine at one-twentieth the ATP-PP, exchange is expressed in jumol of PPi exchanged/l 5min per mg of protein (the protein concentration was determined by Dr. Bruton, who gave us the enzyme) and is also expressed as a percentage of that stimulated by L-methionine under the conditions described. The kinetic parameters for L-methionine and the methionine analogues which were found to support ATP-PPi exchange in Table I were determined with pure methionyl-tRNA synthetase by the method of Lineweaver & Burk (1934 Table 2 . The Km value of 0.02mM obtained for methionine compares favourably with the previously reported values of 0.04mm (Lemoine et al., 1968) and 0.07mM (Bruton & Hartley, 1968) . Ethionine and Lemoine et al. (1968) of 5 and 8mm respectively. Homocysteine had a Km value of 13 mm, whereas norvaline and aaminobutyric acid both had a higher Km value, of 100mM. All five analogues had the same Vmax. value, which was significantly lower than the Vmax. of methionine under the same conditions.
The methionine analogues that did not support ATP-PP1 exchange, L-S-methylcysteine, L-S-ethylcysteine, D-methionine, D-ethionine, D-norleucine and D-norvaline, were tested for their ability to inhibit methionine-stimulated ATP-PP; exchange by the method of Lineweaver & Burk (1934) . No inhibition was observed with any of these analogues. The results for the four D-amino acids confirm that methionyltRNA synthetase exhibits a strict stereospecificity for the L-isomers of methionine and methionine analogues at the methionine-binding site.
The effect of each methionine analogue on the extent of methionyl-tRNA formation by using an E. coli extract as the synthetase preparation and crude E. coli tRNA has been reported (Old & Jones, 1976) . Similar results have been obtained by using pure methionyl-tRNA synthetase and purified tRNAmC"
and tRNAm"C species from E. coli. Table 3 compares the inhibition of formation of methionyl-tRNAmfce and methionyl-tRNAmeI by these analogues at an analogue/methionine molar ratio of 1000:1. Their efficiency of inhibition is in the order: ethic-nine (approx. 85%), homocysteine (approx. 60%), norleucine (approx. 20%) and norvaline and a-an-1,iobutyric acid (approx. 6 %).
Ethionine and norleucine have been shown pre- * These values included a correction to allow for the fact that the DL-racemate was used in the assays (see Old & Jones, 1976) . N viously to be esterified to tRNA in place of methionine (Trupin et al., 1966) . To determine whether analogues which inhibited the extent of methionyltRNA formation (Table 3) are also esterified to tRNA in place of methionine, each analogue was examined by the following criteria. To inhibit the extent of aminoacylation of tRNA, the inhibitor must bind either reversibly or irreversibly to the enzyme. If it binds reversibly but is not esterified to the tRNA molecule, it will inhibit the initial rate of aminoacylation, but not the extent. This possibility is ruled out in our case, as each of the methionine analogues in question has been shown to inhibit the extent of methionyl-tRNA formation (Old & Jones, 1976 Table 4 inhibits the formation of methionyl-tRNA by binding reversibly to the enzyme and being esterified to tRNAMCt in the place of methionine. Table 4 . Effect of methionine analogues on the extent of methionyl-tRNA formation in a two-step incubation assay For each methionine analogue indicated, two basic reaction mixtures were made up, each containing the analogue at a concentration that had been found to inhibit the extent of methionyl-tRNA formation by approx. 30%. After 25min incubation at 37°C, a 50,ul sample from each reaction mixture was assayed for [14C]methionyl-tRNA as previously described (Old & Jones, 1976) . For each analogue 0.15mg of unfractionated tRNA was added to one reaction mixture and 0.06mg of enzyme added to the other. Both reaction mixtures were reincubated for 25min at 37°C and the extent of [14C]methionyltRNA formation assayed as above. The extents of methionyl-tRNA formation are expressed as pmol of methionine incorporated/A260 unit of tRNA. Extent of methionyl-tRNA formation As would be predicted, the five methionine analogues that inhibit the formation of methionyltRNA stimulate the ATP-PP, exchange reaction. To measure the recognition of each analogue at the methionine-binding site, the Km value for each analogue was determined. Ethionine, norleucine and homocysteine had similar Km values, showing that the enzyme recognizes each of the three analogues to a similar extent. However, the Km value for methionine was at least two orders of magnitude lower, showing that the enzyme has a much greater binding affinity for methionine than for ethionine, norleucine and homocysteine. The side chain of norleucine is of a similar size and shape to that of methionine, but it does not possess a sulphur atom. Ethionine and homocysteine have side chains that are different in size to that of methionine, but each possesses a sulphur atom in the same position of the side chain as the sulphur atom in methionine. Norvaline and a-aminobutyric acid have the same Km values, which are an order of magnitude higher than those of L-ethionine, Lnorleucine and DL-homocysteine. The side chains of these analogues are shorter than methionine and lack a sulphur atom.
S-Methylcysteine and S-ethylcysteine were found neither to stimulate ATP-PP, exchange (Table 1) nor to inhibit methionine-dependent ATP-PPi exchange.
This shows that they cannot bind to the methioninebinding site and thus they are not recognized by the enzyme in the first stage of aminoacylation. SMethylcysteine and S-ethylcysteine possess a sulphur atom in their side chains in a position one place nearer to the amino acid backbone than that in methionine. These results suggest that, in the formation of the aminoacyl-AMP-synthetase complex, some variability in the length of side chain is permissible. The sulphur atom may be replaced by carbon (norleucine), oxygen (methoxinine; Richmond, 1962) or selenium (selenomethionine; McConnell & Hoffman, 1972) ; however, when present in the side chain, its position is critical.
The maximum velocity exhibited by an analogue in the ATP-PPI exchange reaction is a measure of its ability to form an aminoacyl-adenylate complex. The methionine analogues had the same Vmax. value, which was only two-thirds the Vmax. ofmethionine under the same conditions. Thus there is a recognition mechanism at the second stage of aminoacylation which discriminates equally against the five methionine analogues. As the side chain of each analogue, even norleucine, is not identical in length with the methionine side chain, one possible explanation of this recognition mechanism is that when each analogue is bound at the methionine-binding site, the (Pauling, 1947) , the latter being the atom which replaces sulphur in norleucine. Bruton & Hartley (1968) recognition mechanism at the third stage of aminoacylation that allows the enzyme to distinguish between methionine and norleucine but not between methionine and ethionine or homocysteine. Our results indicate that it is the sulphur atom that is the recognition factor. Ethionine and homocysteine each possess a sulphur atom in the same position as methionine, whereas norleucine lacks a sulphur atom. E. coli methionyl-tRNA synthetase has been shown to consist of two identical subunits (Koch & Bruton, 1974) and thus the enzyme may be subject to allosteric control mechanisms. The recognition mechanism at the third stage of aminoacylation can be explained by such a mechanism. Fig. I shows a suggested schematic representation of the active site of methionyl-tRNA synthetase incorporating the mechanisms of methionine recognition. It is proposed that the methionine-binding site is a rigid pocket just large enough to accommodate the methionine side chain. Fig. 1(a) shows methionine bound to the active site with its carboxyl group optimally placed for reaction with the bound ATP molecule. The methionine-binding site contains an amino acid (labelled R in Fig. 1 , as our results give no indication as to the nature of the amino acid) which is positioned adjacent to the sulphur atom of the bound methionine side chain. The sulphur atom interacts with the side chain of amino acid R and the interaction induces a conformational change in the enzyme, represented in Fig. 1(b) . The conformational change is illustrated by a pivoting at a hinge point between the methionine-binding site and the tRNAbinding site, resulting in the movement of the bound tRNA molecule to the optimum position for its reaction with the methionyl-adenylate complex. Norleucine lacks a sulphur atom and thus cannot induce this conformational change in the enzyme, resulting in a decrease in the ability of the norleucyladenylate complex to react with the tRNA molecule. As the formation ofthe aminoacyl-adenylate complex is an equilibrium reaction, with the reverse reaction being much faster than the forward reaction (Santi et al., 1974) , a decrease in the ability of the norleucyladenylate complex to react with tRNA will result in a greater breakdown rate of the norleucyl-adenylate complex, thus decreasing the amount of norleucine esterified to tRNA in comparison with ethionine and homocysteine.
The recognition of each methionine analogue can be explained by the model in Fig. 1 . Ethionine has a sulphur atom in the same position as methionine, but the side chain is longer. Thus when ethionine is bound at the methionine-binding site, the sulphur atom is positioned slightly above the amino acid R, but is close enough to interact with it. Homocysteine can also bind with its sulphur atom in the correct position to induce a conformational change. Norleucine, norvaline and a-aminobutyric acid can all bind to the methionine-binding site, but they cannot induce the conformational change. S-Methylcysteine and Sethylcysteine will not fit into the methionine-binding site of the proposed model. If either analogue is positioned in the methionine-binding site with the sulphur atom adjacent to the amino acid R, the amino group assumes a horizontal position and is sterically hindered by the wall of the methionine-binding site.
Thus, to summarize, our results indicate that the mechanism of methionine recognition by E. coli methionyl-tRNA synthetase consists of three steps. The first is at the binding of methionine to the enzyme and involves the recognition of the size, shape and chemical nature of the methionine side chain. The second step is at the formation of the aminoacyl-adenylate complex and involves the correct positioning of the carboxyl group for the reaction to take place. The third is at the stage of methionyl-1977 tRNA formation and involves the recognition of the sulphur atom in the methionine side chain. It is proposed that the sulphur atom interacts with a specific amino acid at the methionine-binding site, inducing a conformational change in the enzyme, resulting in the movement of the bound tRNA molecule to the optimum position for the reaction to take place. A conformational change is the most likely explanation of our results, although other explanations are possible. For example, the sulphur atom could be recognized by the tRNA molecule instead of by the enzyme. If such an interaction is shown to exist, the proposed model is such that it can be easily adapted in the light of further results.
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